Roland Wandeler

Corporate Officer/Principal bij GRIFOLS, S.A.

53 jaar

Health Technology

Consumer Services

Profiel

Roland Wandeler is President-Biopharma Business Unit at Grifols SA since 2024.
Former roles include Chief Executive Officer at Sundance Biosciences, Inc. from 2022 to 2023, VP, GM-US Bone Health & Cardiology Business Unit at Amgen, Inc., and Chief Operating Officer at MorphoSys AG from 2020 to 2021.
Education includes graduate and doctorate degrees from the Swiss Federal Institute of Technology.

Actieve functies van Roland Wandeler

Bedrijven	Functie	Begin
GRIFOLS, S.A.	Corporate Officer/Principal	01-01-2024

Alle actieve functies van Roland Wandeler

Eerdere bekende functies van Roland Wandeler

Bedrijven	Functie	Einde
Encinal Bio, Inc.	Algemeen Directeur	01-10-2023
MORPHOSYS AG	Operationeel Directeur	31-12-2021
AMGEN INC.	Corporate Officer/Principal	-

Ervaring van Roland Wandeler in detail bekijken

Opleiding van Roland Wandeler

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Roland Wandeler in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	5
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Grifols SA Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies	Health Technology
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Encinal Bio, Inc.